GeneLink Inc. reported earnings results for the fiscal year ended December 31, 2011. For the year, the company announced annual net sales decreased from $7,839,972 to $4,684,577 as GeneWize struggled during the year to maintain their brand partner enthusiasm in advance of the sale and while combating competitive pressures. In addition, anticipated revenues from the launch of other channels were delayed. The operating loss in 2011 was $3,566,615. Most of the loss is attributable to the reduction in sales in GeneWize and implementation of plans to support GeneLink's expansion into additional channels.